InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

- Current share price for ARX : $0.575

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$199 Notification of Full Year Results Webinar 24 May 2023 8:47AM $0.920 $0.575 fallen by 37.50%
$199 Investor Presentation 27 Apr 2023 8:41AM $1.010 $0.575 fallen by 43.07%
$199 March 2023 Quarterly Report and Appendix 4C 27 Apr 2023 8:39AM $1.010 $0.575 fallen by 43.07%
$199 Notification of Quarterly Results Webinar 20 Apr 2023 8:39AM $1.050 $0.575 fallen by 45.24%
$199 Notification regarding unquoted securities - ARX 12 Apr 2023 12:50PM $1.050 $0.575 fallen by 45.24%
$199 AROA secures first FDA clearance for ENIVO system 12 Apr 2023 9:05AM $1.060 $0.575 fallen by 45.75%
$199 Release of Shares from Voluntary Escrow 4 Apr 2023 12:49PM $1.075 $0.575 fallen by 46.51%
$199 Change of Director's Interest Notice - SE 31 Mar 2023 2:50PM $1.060 $0.575 fallen by 45.75%
$199 Change of Director's Interest Notice - JP 31 Mar 2023 2:48PM $1.060 $0.575 fallen by 45.75%
$199 Change of Director's Interest Notice - JM 31 Mar 2023 2:46PM $1.060 $0.575 fallen by 45.75%
$199 Change of Director's Interest Notice - BW 31 Mar 2023 2:45PM $1.060 $0.575 fallen by 45.75%
$199 Change of Director's Interest Notice - PM 31 Mar 2023 2:43PM $1.060 $0.575 fallen by 45.75%
$199 Change of Director's Interest Notice - JD 31 Mar 2023 2:41PM $1.060 $0.575 fallen by 45.75%
$199 Notification regarding unquoted securities - ARX 31 Mar 2023 2:35PM $1.060 $0.575 fallen by 45.75%
$199 Aroa awarded agreement with Premier Inc 6 Mar 2023 8:50AM $1.100 $0.575 fallen by 47.73%
$199 Application for quotation of securities - ARX 3 Feb 2023 2:51PM $1.145 $0.575 fallen by 49.78%
$199 Section 708A Notice 3 Feb 2023 2:49PM $1.140 $0.575 fallen by 49.56%
$199 Investor Presentation 31 Jan 2023 10:49AM $1.240 $0.575 fallen by 53.63%
$199 December 2022 Quarterly Report and Appendix 4C 31 Jan 2023 9:12AM $1.235 $0.575 fallen by 53.44%
$199 Notification of Quarterly Results Webinar 24 Jan 2023 10:02AM $1.210 $0.575 fallen by 52.48%
$199 Notification of cessation of securities - ARX 12 Jan 2023 2:21PM $1.160 $0.575 fallen by 50.43%
$199 Notification of cessation of securities - ARX 11 Jan 2023 10:13AM $1.175 $0.575 fallen by 51.06%
$199 Notification regarding unquoted securities - ARX 5 Jan 2023 10:32AM $1.130 $0.575 fallen by 49.12%
$199 Change of Director's Interest Notice - JD 16 Dec 2022 10:20AM $1.055 $0.575 fallen by 45.50%
$199 Notification regarding unquoted securities - ARX 16 Dec 2022 10:17AM $1.055 $0.575 fallen by 45.50%

176 - 200 of 762 results

Page 8 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.